Biomerica Inc posts $1.11 million revenue in quarter ended Feb 28, 2023
By USInMinutes - Apr 16, 2023, 10:54 PM ET
Last Updated - Jul 18, 2023, 03:55 PM EDT
Key fundamental financials
loss of $1.65 million
Revenue of $1.11 million
Biomerica Inc [BMRA] has reported $1.65 million loss for the fiscal quarter ending Feb 28, 2023.
Revenue for the quarter was $1.11 million with operating income of $1.65 million.
The Irvine, California (CA)-based company operating in the in vitro & in vivo diagnostic substances sector has total shareholders equity of $5.99 million.